DEMETRA
LIVE

Serial Number

79437034

Owner

DEMETRA HOLDING S.P.A.

Attorney

James Bitetto

Filing Date

Jul 31, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DEMETRA Trademark

Serial Number: 79437034

DEMETRA is a trademark filed by DEMETRA HOLDING S.P.A. on July 31, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

DEMETRA HOLDING S.P.A.

Corso Monforte, 16

Entity Type: 09

Trademark Details

Filing Date

July 31, 2025

Registration Date

Not Registered

Goods & Services

Medical apparatus and instruments for use in surgery; Medical instruments, namely, orthopedic apparatus and instruments; Surgical apparatus and instruments for medical, dental or veterinary use; artificial limbs, eyes and teeth; suture materials; massage apparatus; medical devices, instruments and apparatus for orthopedics, neurosurgery, vertebroplasty and cranioplasty namely, endorthesis screws, cannulae and connectors, trials and templates for spacers, cranial implants PMMA based; medical devices for preparing, mixing and extruding bone cement; fluid injectors for medical purposes; spacers for surgical and orthopedic use; surgical prostheses, namely, bone prostheses, joint prostheses; bone prosthesis; bone substitutes for surgical use; orthopedic articles, namely, for treatment, diagnosis and/or prevention of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies.

Scientific research for medical purposes.

Organization and conducting of cultural activities; training in the field of medicine; organization of seminars and conventions in the field of medicine.

Medical services; veterinary services; hygienic and beauty care for human beings or animals.

Pharmaceutical preparations for the treatment of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; medical and veterinary preparations for the treatment of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; sanitary preparations for medical use; food for babies; dietary supplements for human beings and animals; adhesive plasters for medical purposes; materials for dressings, namely, medical dressings; dental composite materials for stopping the teeth and moulding wax for dentists; disinfectants; vermin destroying preparations; fungicides; herbicides; pharmaceutical preparations for bone surgery; chemical preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; chemical preparations for pharmaceutical purposes, namely, for treatment, diagnosis and/or prevention of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; chemico-pharmaceutical preparations for the treatment of musculoskeletal disorders, septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; veterinary preparations for treatment, diagnosis and/or prevention of septic and aseptic bone, soft tissues, joint diseases and spine diseases; sanitary preparations for medical purposes; bone fillers consisting of living materials; acrylic resin for bone surgery; acrylic resin for cranioplasty and vertebroplasty; acrylic resin for neurosurgery, traumatology and orthopedics; bone cement for medical purposes; bone cement suitable for orthopedic use; bone cement suitable for veterinary purposes; bone cement with fluorine salts added for medical and veterinary purposes.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2026 TROA
REFUSAL PROCESSED BY IB
Feb 26, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 12, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 11, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 15, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 14, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 13, 2025 REPR